Partner Content Protected: Optimising outcome measures in cognitive drug trials for schizophrenia There is no excerpt because this is a protected post. October 9, 2024 Share Copy Link Share on X Share on Linkedin Share on Facebook Traditional pen and paper cognitive assessment measures are often burdensome and time-consuming. Image credit: illustrissima via Shutterstock This content is password protected. To view it please enter your password below: Password: Sign up for our daily news round-up! Give your business an edge with our leading industry insights. Sign up